Cbn and sleep quality
Pro Research Analysisby 
Searched over 200M research papers
CBN and Sleep Quality: Clinical Trial Evidence
Recent research has focused on the potential of cannabinol (CBN), a non-intoxicating cannabinoid, to improve sleep quality. Several randomized, double-blind, placebo-controlled trials have explored CBN’s effects on sleep in adults with sleep disturbances or insomnia disorder.
Efficacy of CBN for Sleep Improvement
A large clinical trial with over 1,000 participants found that a 50 mg dose of CBN significantly improved sleep quality compared to placebo, with most participants experiencing a clinically important improvement. The effect of 50 mg CBN was slightly better than 4 mg melatonin, and all tested CBN doses (25 mg, 50 mg, 100 mg) were statistically equivalent to melatonin for improving sleep quality. Side effects were mild or moderate and similar across all groups, including placebo and melatonin, suggesting CBN is well-tolerated as a sleep aid .
Other studies have designed protocols to test CBN at doses of 30 mg and 300 mg in adults with diagnosed insomnia, using objective sleep measures like polysomnography and next-day function tests. These studies aim to provide preliminary data on CBN’s effects on sleep continuity, sleep architecture, and next-day performance, which will inform larger clinical trials. However, results from these trials are still pending, and current evidence is limited to protocol descriptions and pilot data 234.
CBN in Combination with Other Cannabinoids and Melatonin
Trials comparing CBN in combination with cannabidiol (CBD) and/or melatonin found that adding low doses of CBN (15 mg) to CBD or melatonin did not significantly improve sleep quality beyond what was achieved with CBD or melatonin alone. All formulations, including those with CBN, were safe and led to significant improvements in sleep disturbance, but the effects did not exceed those of 5 mg melatonin. This suggests that low-dose CBN may not provide additional sleep benefits when combined with other common sleep aids 56.
Safety and Drug Interactions
CBN appears to have a favorable safety profile, with mild or moderate side effects similar to placebo and melatonin. However, preclinical research indicates that CBN can inhibit the metabolism of melatonin, potentially increasing melatonin’s effects when the two are taken together. This drug-drug interaction could lead to higher melatonin exposure, which may have implications for safety and efficacy in combined products .
Limitations and Need for Further Research
Despite promising early results, a recent review highlights that clinical evidence supporting CBN’s sleep-promoting effects is still limited. Most human studies to date have small sample sizes or lack rigorous sleep assessments. There is a need for more well-designed randomized controlled trials using validated sleep measures and higher CBN doses than those typically found in commercial products .
Conclusion
Current evidence suggests that CBN, particularly at moderate doses (around 50 mg), may improve sleep quality and is as effective as melatonin, with a similar safety profile. However, low-dose CBN does not appear to enhance the effects of CBD or melatonin when used in combination. While CBN is a promising candidate for sleep enhancement, more robust clinical trials are needed to confirm its efficacy and safety, especially in people with insomnia or chronic sleep disturbances 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic
The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial
Chronic use of low doses of CBD is safe and can improve sleep quality, but effects do not exceed those of 5 mg melatonin, and the addition of minor cannabinoids may not enhance these effects.
DOI